Caribou Biosciences Company
Caribou Biosciences is a biotechnology company that develops CRISPR technologies and allogenic cell therapies for oncology.
Investors
Headquarters:
Berkeley, California, United States
Number Of Exists:
1
Total Funding:
167549904
Founded Date:
2011
Employee Number:
101-250
Investment Stage:
N/A
Last Funding Type:
Series C
Investor Type:
Late Stage Venture
Investors Number:
28
Last Funding Date:
2021
Technology:
Others
Funding Status:
Late Stage Venture
Estimated Revenue:
$10M to $50M
Industry:
Biotechnology, Health Care, Therapeutics